Search results
Results from the WOW.Com Content Network
Cannabis use disorder is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders as a condition requiring treatment. [107] Several drugs have been investigated in an attempt to ameliorate the symptoms of stopping cannabis use. Such drugs include bupropion, divalproex, nefazodone, lofexidine, and dronabinol.
Daily marijuana use among young adults has risen to record highs, with more than 1 in 10 of young adults ages 19-30 now reporting daily use, and almost half reporting use within the last year ...
The findings on marijuana's relationship to depressive disorder are scattered, showing that cannabis use has benefits, but can also be detrimental to overall mental health. However, sufficient evidence exists showing reductions in cannabis use improve anxiety, depression, and sleep quality. [51]
The 74 reports on how cannabis use has increased among teens and young adults with negative impact on their brains. 'Behind the 8 ball': How research is trying to catch up on cannabis and kids ...
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Marijuana use is at an all-time high in the United States. In the past decade alone, Americans' reported marijuana smoking has more than doubled, increasing from 7% to 13% from 2013 to 2023 ...
As many as half of people with cannabis-induced psychosis may go on to develop either schizophrenia or bipolar disorder, research suggests. Young adults and teenagers should be especially ...
For the treatment of the withdrawal/negative affect symptom domain of cannabis use disorder, medications may work by alleviating restlessness, irritable or depressed mood, anxiety, and insomnia. [58] Bupropion , which is a norepinephrine–dopamine reuptake inhibitor , has been studied for the treatment of withdrawal with largely poor results ...